NCT07214142View on ClinicalTrials.gov

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions

Rectal Cancer Patients

Interventions

DRUG

PD-1

patients will receive short-course chemotherapy and concurrent PD-1

All Listed Sponsors

lead

The First Affiliated Hospital of University of Science and Technology of China

OTHER